- 大麻会在 12月31日 前重新分类吗？11¢11%
The DEA administrative process for moving botanical marijuana from Schedule I to Schedule III remains in a limited briefing phase following an October 22 order from Chief ALJ Derek Julius. That ruling admitted a September GAO report highlighting gaps in federal scheduling procedures but denied requests to reopen the June-July 2026 hearings for additional testimony. Optional briefs on the report’s weight are due by November 5, after which the stay lifts and the judge can issue a nonbinding recommendation. An April 2026 Attorney General order already placed state-licensed medical marijuana and FDA-approved products into Schedule III, with the DEA issuing initial federal registrations to over 900 dispensaries in seven states as the first implementation step. Broader rescheduling covering adult-use cannabis requires the full hearing record, agency decision, and potential further review, keeping near-term resolution unlikely.
规则
如果美国缉毒局（https://www.dea.gov/drug-information/drug-scheduling）在 2026年12月31日 23:59 ET 前将大麻从附表 I 降级到任何其他级别（或完全取消管制），此市场将判定为“是”。否则，本市场将以“否”结算。 此市场判定的主要依据将是美国政府的官方信息，但也会参考可信报道形成的共识。
机器翻译。如有争议，以原文为准。